FindTrial
Sign In

Role of PET-CT imaging in evaluation of Hepatocellular carcinoma

Prospective analysis of role of PSMA PET-CT in evaluation of Hepatocellular Carcinoma patients at Army Hospital R & R, Delhi: A pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/02/023206
Enrollment
24
Registered
2020-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C220- Liver cell carcinoma

Interventions

None listed

Sponsors

Abhishek Mahato
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients of HCC being evaluated and treated at Army Hospital Research and Referral New Delhi

Exclusion criteria

Exclusion criteria: Pregnant ladies

Design outcomes

Primary

MeasureTime frame
To assess PSMA expression profile of HCCTimepoint: 1 year—

Secondary

MeasureTime frame
Correlation of PSMA expression with AFP(Alpha Feto Protein)Timepoint: Single time point study;Correlation of PSMA PET-CT with current imaging modalities (CECT and USG)Timepoint: Single time point—

Countries

India

Contacts

Public ContactAbhishek Mahato

Army Hospital Research and Referral

dr.abhi22ndleo@gmail.com23338190

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026